|Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of …|
S Slavin, A Nagler, E Naparstek, Y Kapelushnik, M Aker, G Cividalli, ...
Blood, The Journal of the American Society of Hematology 91 (3), 756-763, 1998
|Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4|
A Peled, I Petit, O Kollet, M Magid, T Ponomaryov, T Byk, A Nagler, ...
Science 283 (5403), 845-848, 1999
|G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4|
I Petit, M Szyper-Kravitz, A Nagler, M Lahav, A Peled, L Habler, ...
Nature immunology 3 (7), 687-694, 2002
|The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34+ cells: role in transendothelial/stromal migration and …|
A Peled, O Kollet, T Ponomaryov, I Petit, S Franitza, V Grabovsky, ...
Blood, The Journal of the American Society of Hematology 95 (11), 3289-3296, 2000
|HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver|
O Kollet, S Shivtiel, YQ Chen, J Suriawinata, SN Thung, MD Dabeva, ...
The Journal of clinical investigation 112 (2), 160-169, 2003
|Comparative studies of human FcRIII-positive and negative natural killer cells.|
A Nagler, LL Lanier, S Cwirla, JH Phillips
The Journal of Immunology 143 (10), 3183-3191, 1989
|Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies|
R Berger, R Rotem-Yehudar, G Slama, S Landes, A Kneller, M Leiba, ...
Clinical Cancer Research 14 (10), 3044-3051, 2008
|Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy …|
RZ Orlowski, A Nagler, P Sonneveld, J Bladé, R Hajek, A Spencer, ...
Journal of Clinical Oncology 25 (25), 3892-3901, 2007
|Autologous transplantation and maintenance therapy in multiple myeloma|
A Palumbo, F Cavallo, F Gay, F Di Raimondo, D Ben Yehuda, MT Petrucci, ...
New England Journal of Medicine 371 (10), 895-905, 2014
|Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function|
T Ponomaryov, A Peled, I Petit, RS Taichman, L Habler, J Sandbank, ...
The Journal of clinical investigation 106 (11), 1331-1339, 2000
|CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow|
A Avigdor, P Goichberg, S Shivtiel, A Dar, A Peled, S Samira, O Kollet, ...
Blood 103 (8), 2981-2989, 2004
|Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation|
S Slavin, E Naparstek, A Nagler, A Ackerstein, S Samuel, J Kapelushnik, ...
|Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients|
MJ Besser, R Shapira-Frommer, AJ Treves, D Zippel, O Itzhaki, ...
Clinical cancer research 16 (9), 2646-2655, 2010
|Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results …|
P Armand, A Nagler, EA Weller, SM Devine, DE Avigan, YB Chen, ...
Journal of clinical oncology 31 (33), 4199, 2013
|Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older …|
M Aoudjhane, M Labopin, NC Gorin, A Shimoni, T Ruutu, HJ Kolb, ...
Leukemia 19 (12), 2304-2312, 2005
|Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease|
F Locatelli, V Rocha, W Reed, F Bernaudin, M Ertem, S Grafakos, ...
Blood, The Journal of the American Society of Hematology 101 (6), 2137-2143, 2003
|Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk …|
C Schmid, M Labopin, A Nagler, M Bornhäuser, J Finke, A Fassas, ...
Journal of clinical oncology 25 (31), 4938-4945, 2007
|Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib|
C Gambacorti-Passerini, L Antolini, FX Mahon, F Guilhot, M Deininger, ...
Journal of the National Cancer Institute 103 (7), 553-561, 2011
|Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse|
M Levis, F Ravandi, ES Wang, MR Baer, A Perl, S Coutre, H Erba, ...
Blood, The Journal of the American Society of Hematology 117 (12), 3294-3301, 2011
|Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually|
JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ...
Bone marrow transplantation 51 (6), 786-792, 2016